Equities research analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Get Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock.
NYSE:MLSS opened at $0.95 on Wednesday. Milestone Scientific has a 1-year low of $0.75 and a 1-year high of $3.00. The firm has a 50-day moving average of $0.97. The firm has a market capitalization of $65.01 million, a price-to-earnings ratio of -7.92 and a beta of 1.45.
Milestone Scientific (NYSE:MLSS – Get Rating) last released its earnings results on Tuesday, May 17th. The company reported ($0.03) earnings per share for the quarter. Milestone Scientific had a negative net margin of 76.86% and a negative return on equity of 47.99%. The company had revenue of $2.70 million during the quarter.
Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.
- Get a free copy of the StockNews.com research report on Milestone Scientific (MLSS)
- Are These Cheap Copper Stocks Right For Your Portfolio?
- Zai Lab Stock Has Fallen to Value Levels
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.